2010年加拿大美国全球医药场分析 [IMS出品].pdf

The US, Canadian Global Pharmaceutical Market: What’s In?, What’s Out? and What’s Ahead? BY: Doug Long, VP Industry Relations Presented to AQPP October 29, 2011 2011 Strategic management presentation All reproduction rights, quotations, broadcasting, publications reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without express written consent of IMS HEALTH. The global pharmaceutical market performance declined in 2010 Global Pharma Historical Market Dynamics Current Environment Global Sales and Market Growth Pharma market challenges • The US/top 5 Europe/Japan no longer the main growth drivers • The economic crisis impact has been different across pharmaceutical markets • New product launches are not replacing revenues lost to generic competition, especially in primary care • The most attractive areas for growth are in emerging, generics and specialty markets Source: IMS Health, MIDAS, Dec 2010 Top 10 markets sales and growth Audited markets in 2010 2010 Sales, US $ % Market % Growth,